News

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

908 Devices to Participate in Upcoming Investor Conferences

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

908 Devices reports its second-quarter 2024 financial results, showcasing a 16% revenue growth, driven by handheld devices.